Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
PEGS Boston SummitPEGS Boston Summit
Not Confirmed
Not Confirmed
11 May-15 November, 2026
STLE Annual MeetingSTLE Annual Meeting
Not Confirmed
Not Confirmed
17-21 May, 2026
Biogas AmericasBiogas Americas
Not Confirmed
Not Confirmed
18-21 May, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
PEGS Boston SummitPEGS Boston Summit
Industry Trade Show
Not Confirmed
11 May-15 November, 2026
STLE Annual MeetingSTLE Annual Meeting
Industry Trade Show
Not Confirmed
17-21 May, 2026
Biogas AmericasBiogas Americas
Industry Trade Show
Not Confirmed
18-21 May, 2026
Digital content

28 Apr 2026
// PHARMIWEB
https://www.pharmiweb.com/press-release/2026-04-28/us-food-and-drug-administration-accepts-new-drug-application-for-zipalertinib-for-the-treatment-of

10 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/10/3252628/0/en/Cullinan-Therapeutics-Provides-Corporate-Update-and-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results.html

24 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/24/3243377/0/en/Cullinan-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html

18 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/18/3240062/0/en/Cullinan-Therapeutics-to-Participate-in-Fireside-Chat-at-the-Citi-2026-Virtual-Oncology-Leadership-Summit.html

05 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/05/3232850/0/en/Cullinan-Therapeutics-to-Participate-in-Fireside-Chat-at-the-Guggenheim-Emerging-Outlook-Biotech-Summit-2026.html

08 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/08/3215212/0/en/Cullinan-Therapeutics-Provides-Corporate-Update-and-Highlights-Anticipated-2026-Milestones.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE